Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus

Virology

Volumn 225, Issue 1, 1996, Pages 97-110

  Giammarioli, Anna Maria ^a   Mackow, Erich R ^b   Fiore, Lucia ^a   Greenberg, Harry B ^c,d   Ruggeri, Franco M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b STONY BROOK UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; IMMUNOGLOBULIN A; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; ROTAVIRUS; VIRUS NEUTRALIZATION;

ANIMALIA; MACACA MULATTA; MIRIDAE; MURINAE; RHESUS ROTAVIRUS; ROTAVIRUS;

EID: 0030296731     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0578     Document Type: Article

References (70)

1. Andrew, M. E., Boyle, D. B., Coupar, B. E., Reddy, D., Bellamy, A. R., and Both, G. W. (1992). Vaccinia-rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea. Vaccine 10, 185-191.
2. Andrew, M. E., Boyle, D. B., Coupar, B. E., Whitfeld, P. L., Both, G. W., and Bellamy, A. R. (1987). Vaccinia virus recombinants expressing the SA11 rotavirus VP7 glycoprotein gene induce serotype-specific neutralizing antibodies. J. Virol. 61, 1054-1060.
3. Andrew, M. E., Boyle, D. B., Whitfeld, P. L., Lockett, L J., Anthony, I. D., Bellamy, A. R., and Both, G. W. (1990). The immunogenicity of VP7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression. J. Virol. 64, 4776-4783.
4. Arias, C. F., Ballado, T., and Plebanski, M. (1986). Synthesis of the outer-capsid glycoprotein of the simian rotavirus SA11 in Escherichia coli. Gene 47, 211-219.
5. Bastardo, J. W., McKimm, B. J., Sonza, S., Mercer, L. D., and Holmes, I. H. (1981). Preparation and characterization of antisera to electrophoretically purified SA11 virus polypeptides. Infect. Immun. 34, 641-647.
6. Burns, J. W., Greenberg, H. B., Shaw, R. D., and Estes, M. K. (1988). Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J. Virol. 62, 2164-2172.
7. Burns, J. W., Siadat-Pajouh, M., Krishnaney, A. A., and Greenberg, H. B. (1996). Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272, 104-107.
8. Chen, K.-S., and Strober, W. (1990). Cholera holotoxin and its B subunit enhance Peyer's patches B cell responses induced by orally administered influenza virus: Disproportionate cholera toxin enhancement of the IgA B cell response. Eur. J. Immunol. 20, 433-436.
9. Coffin, S. E., Klinek, M., and Offit, P. A. (1995). Induction of virus-specific antibody production by lamina propria lymphocytes following intra-muscular inoculation with rotavirus. J. Infect. Dis. 172, 874-878.
10. Conner, M. E., Gilger, M. A., Estes, M. K., and Graham, D. Y. (1991). Serologic and mucosal immune response to rotavirus infection in the rabbit model. J. Virol. 65, 2562-2571.
11. Coulson, B. S., Grimwood, K., Hudson, I. L., Barnes, G. L., and Bishop, R. F. (1992). Role of coproantibody in clinical protection of children during reinfection with rotavirus. J. Clin. Microbiol. 30, 1678-1684.
12. Dharakul, T., Riepenhoff, T. M., Albini, B., and Ogra, P. L. (1988). Distribution of rotavirus antigen in intestinal lymphoid tissues: Potential role in development of the mucosal immune response to rotavirus. Clin. Exp. Immunol. 74, 14-19.
13. Dormitzer, P. R., Both, G. W., and Greenberg, H. B. (1994). Presentation of neutralizing epitopes by engineered rotavirus VP7s expressed by recombinant vaccinia viruses. Virology 204, 391-402.
14. Dyall, S. M., Lazdins, I., Tregear, G. W., and Holmes, I. H. (1986). Location of the major antigenic sites involved in rotavirus serotype-specific neutralization. Proc. Natl. Acad. Sci. USA 83, 3465-3468.
15. Estes, M. K., Graham, D. Y., and Mason, B. B. (1981). Proteolytic enhancement of rotavirus infectivity: Molecular mechanisms. J. Virol. 39, 879-888.
16. Fiore, L., Greenberg, H. B., and Mackow, E. R. (1991). The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology 181, 553-563.
17. Flores, J., Myslinski, J., Kalica, A. R., Greenberg, H. B., Wyatt, R. G., Kapikian, A. Z., and Chanock, R. M. (1982). In vitro transcription of two human rotaviruses. J. Virol. 43, 1032-1037.
18. Gerna, G., Battaglia, M., Milanesi, G., Passarani, N., Percivalle, E., and Cattaneo, E. (1984). Serotyping of cell culture-adapted subgroup 2 human rotavirus strains by neutralization. Infect. Immun. 43, 722-729.
19. Gorziglia, M., Larralde, G., Kapikian, A. Z., and Chanock, R. M. (1990). Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. Proc. Natl. Acad. Sci. USA 87, 7155-7159.
20. Greenberg, H. B., Flores, J., Kalica, A. R., Wyatt, R. G., and Jones, R. (1983a). Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J. Gen. Virol. 64, 313-320.
21. Greenberg, H. B., Valdesuso, J., Van Wyke, K., Midthun, K., Walsh, M., McAulliffe, V., Wyatt, R. G., Kalica, A. R., Flores, J., and Hoshino, Y. (1983b). Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J. Virol. 47, 267-275.
22. Hoshino, Y., Sereno, M. M., Midthun, K., Flore, J., Kapikian, A. Z., and Chanock, R. M. (1985). Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc. Natl. Acad. Sci. USA 82, 8701 -8704.
23. Kaetzel, C. S., Robinson, J. K., Chintalacharuvu, K. R., Vaerman, J., and Lamm, M. E. (1991). The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: A local defense function for IgA. Proc. Natl. Acad. Sci. USA 88, 8796-8800.
24. Kalica, A. R., Flores, J., and Greenberg, H. B. (1983). Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology 125, 194-205.
25. Kalica, A. R., Greenberg, H. B., Wyatt, R. G., Flores, J., Sereno, M. M., Kapikian, A. Z., and Chanock, R. M. (1981). Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology 112, 385-390.
26. Kapikian, A. Z., and Chanock, R. M. (1990). Rotaviruses. In "Virology" (B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, L. M. Joseph, T. P. Monath, and B. Roizman, Eds.), 2nd ed., pp. 1353-1404. Raven Press, New York.
27. Kraehenbuhl, J.-P., and Neutra, M. R. (1992). Molecular and cellular basis of immune protection of mucosal surfaces. Physiol. Rev. 72, 853-880.
28. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227, 680-685.
29. Lazdins, I., Sonza, S., Dyall-Smith, M., Coulson, B., and Holmes, I. (1985). Demonstration of an immunodominant neutralization site by analysis of antigenic variants of SA11 rotavirus. J. Virol. 56, 317-319.
30. Liew, F. Y., Russell, S. M., Appleyard, G., Brand, C. M., and Beale, J. (1984). Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 14, 350-356.
31. Losonsky, G. A., Rennels, M. B., Lim, Y., Krall, G., Kapikian, A. Z., and Levine, M. M. (1988). Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006. Pediatr. Infect. Dis. J. 7, 388-393.
32. Lycke, N., and Holmgren, J. (1986). Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59, 301-308.
33. Mackow, E. R., Barnett, J. W., Chan, H., and Greenberg, H. B. (1989). The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J. Virol. 63, 1661-1668.
34. Mackow, E. R., Shaw, R. D., Matsui, S. M., Vo, P. T., Benfield, D. A., and Greenberg, H. B. (1988a). Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus. Virology 165, 511-517.
35. Mackow, E. R., Shaw, R. D., Matsui, S. M., Vo, P. T., Dang, M. N., and Greenberg, H. B. (1988b). The rhesus rotavirus gene encoding protein VP3: Location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc. Natl. Acad. Sci. USA 85, 645-649.
36. Matsui, S. M., Offit, P. A., Vo, P. T., Mackow, E. R., Benfield, D. A., Shaw, R. D., Padilla, N. L., and Greenberg, H. B. (1989). Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J. Clin. Microbiol. 27, 780-782.
37. Mazanek, M. B., Kaetzel, C. S., Lamm, M. E., Fletcher, D., and Nedrud, J. G. (1992). Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA 89, 6901 -6905.
38. McCrae, M. A., and McCorquodale, J. G. (1987). Expression of a major bovine rotavirus neutralization antigen (VP7c) in Escherichia coli. Gene 55, 9-18.
39. McGonigal, T. P., Turon, M. C., Komar, H. K., Kister, S. E., and Smith, R. E. (1992). Expression of the gene coding for the major outer capsid protein of SA-11 rotavirus in a baculovirus system. Virus Res. 23, 135-150.
40. Mendez, E., Arias, C. F., and Lopez, S. (1993). Binding to sialic acids is not an essential step for the entry of animal rotaviruses into epithelial cells in culture. J. Virol. 67, 5253-5259.
41. Merchant, A. A., Groene, W. S., Cheng, E. H., and Shaw, R. D. (1991). Murine intestinal antibody response to heterologous rotavirus infection. J. Clin. Microbiol. 29, 1693-1701.
42. Mills, J. V., Van Kirk, J. E., Wright, P. F., and Chanock, R. M. (1971). Experimental respiratory syncitial virus infection of adults. Possible mechanisms of resistance to infection and illness. J. Immunol. 107, 123-130.
43. Nagesha, H. S., and Holmes, I. H. (1991). VP4 relationships between porcine and other rotavirus serotypes. Arch. Virol. 116, 107-118.
44. Offit, P.A., and Blavat, G. (1986a). Identification of the two rotavirus genes determining neutralization specificities. J. Virol. 57, 376-378.
45. Offit, P. A., Shaw, R. D., and Greenberg, H. B. (1986b). Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J. Virol. 58, 700-703.
46. Prasad, B. V., Burns, J. W., Marietta, E., Estes, M. K., and Chiu, W. (1990). Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy. Nature (London) 343, 476-479.
47. Prasad, B. V., Wang, G. J., Clerx, J. P., and Chiu, W. (1988). Three-dimensional structure of rotavirus. J. Mol. Bol. 199, 269-275.
48. Renegar, K. B., and Small, P. A., Jr. (1991). Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 65, 2146-2148.
49. Riepenhoff, T. M., Lee, P. C., Carmody, P. J., Barrett, H. J., and Ogra, P. L. (1982). Age-dependent rotavirus-enterocyte interactions. Proc. Soc. Exp. Biol. Med. 170, 146-154.
50. Ruggeri, F. M., and Greenberg, H. B. (1991). Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J. Virol. 65, 2211-2219.
51. Sabara, M., Barrington, A., and Babiuk, L. A. (1985). Immunogenicity of a bovine rotavirus glycoprotein fragment. J. Virol. 56, 1037-1040.
52. Saif, L. J., Redman, D., Smith, K., and Theil, K. (1983). Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from immunized or non-immunized cows. Infect. Immun. 41, 1118-1131.
53. Saif, L. J., Rosen, B. I., and Parwani, A. V. (1994). Animal rotavirus. In "Viral Infections of the Gastrointestinal Tract" (A. Z. Kapikian, Ed.), pp. 279-368. Dekker, New York.
54. Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
55. Shaw, R. D., Fong, K. J., Losonsky, G. A., Levine, M. M., Maldonado, Y., Yolken, R., Flores, J., Kapikian, A. Z., Vo, P. T., and Greenberg, H. B. (1987). Epitope-specific immune responses to rotavirus vaccination. Gastroenterology 93, 941-950.
56. Shaw, R. D., Mackow, E. R., Dyall, S. M., Lazdins, I., Holmes, I. H., and Greenberg, H. B. (1988). Serotypic analysis of VP3 and VP7 neutralization escape mutants of rhesus rotavirus. J. Virol. 62, 3509-3512.
57. Shaw, R. D., Stoner-Ma, D., Estes, M., and Greenberg, H. (1985). Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J. Clin. Microbiol. 22, 286-291.
58. Shaw, R. D., Vo, P. T., Offit, P. A., Coulson, B. S., and Greenberg, H. B. (1986). Antigenic mapping of the surface proteins of rhesus rotavirus. Virology 155, 434-451.
59. Snodgrass, D., and Well, P. (1976). Rotavirus infection in lambs: Studies on passive protection. Arch. Virol. 52, 201 -205.
60. Solari, R., and Kraehenbhul, J.-P. (1985). The biosynthesis of secretory component and its role in the transepithelial transport of IgA dimer. Immunol. Today 6, 17-20.
61. Svensson, L., Sheshberadaran, H., Vene, S., Norrby, E., Grandien, M., and Wadell, G. (1987). Serum antibody responses to individual viral polypeptides in human rotavirus infections. J. Gen. Virol. 68, 643-651.
62. Taniguchi, K., Hoshino, Y., Nishikawa, K., Green, K. Y., Maloy, W. L., Morita, Y., Urasawa, S., Kapikian, A. Z., Chanock, R. M., and Gorziglia, M. (1988a). Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: Nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies. J. Virol. 62, 1870-1874.
63. Taniguchi, K., Maloy, W. L., Nishikawa, K., Green, K. Y., Hoshino, Y., Urasawa, S., Kapikian, A. Z., Chanock, R. M., and Gorziglia, M. (1988b). Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J. Virol. 62, 2421-2426.
64. Taniguchi, K., Morita, Y., Urasawa, T., and Urasawa, S. (1987). Cross-reactive neutralization epitopes on VP3 of human rotavirus: Analysis with monoclonal antibodies and antigenic variants. J. Virol. 61, 1726-1730.
65. Taniguchi, K., Nishikawa, K., Urasawa, T., Urasawa, S., Midthun, K., Kapikian, A. Z., and Gorziglia, M. (1989). Complete nucleotide sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopes. J. Virol. 63, 4101-4106.
66. Taniguchi, K., Urasawa, S., and Urasawa, T. (1985). Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses. J. Gen. Virol. 66, 1045-1053.
67. Ward, R. L., Knowlton, D. R., Schiff, G. M., Hoshino, Y., and Greenberg, H. B. (1988). Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J. Virol. 62, 1543-1549.
68. Ward, R. L., McNeal, M. M., Sander, D. S., Greenberg, H. B., and Bernstein, D. I. (1993). Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children. J. Virol. 67, 464-468.
69. Zagursky, R., Baumeister, K., Lomax, N., and Berman, M. (1985). Dideoxy DNA sequencing directly from plasmid DNA using reverse transcriptase. Gene Anal. Tech. 2, 5-11.
70. Zhou, Y. J., Burns, J. W., Morita, Y., Tanaka, T., and Estes, M. K. (1994). Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure. J. Virol. 68, 3955-3964.